# AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

> **NCT00535353** · PHASE1 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 26 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** irinotecan hydrochloride
- **DRUG:** olaparib

## Key facts

- **NCT ID:** NCT00535353
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01-02
- **Primary completion:** 2012-09-25
- **Final completion:** 2015-02-13
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2023-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00535353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00535353, "AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00535353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*